Sahabi Kabir Sulaiman

Dr. Sahabi Kabir Sulaiman

Yobe State University, Damaturu, Yobe, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
MMMuhammad Sale Musa
Muhammad Sale Musa
FTFatimah Ismail Tsiga-Ahmed
Fatimah Ismail Tsiga-Ahmed
FDFarouq Dayyab
Farouq Dayyab
ASAbdulwahab Kabir Sulaiman
Abdulwahab Kabir Sulaiman
ABAbdulaziz Tijjani Bako
Abdulaziz Tijjani Bako
Introduction: Malaria is the second leading cause of death in children after diarrheal disease, with low- and middle-income countries (LMICs) accounting for over 9 in 10 incidence and deaths. Widespread acceptance and uptake of the RTS,S vaccine, recently approved by the world health organization (WHO), is projected to significantly reduce malaria incidence and deaths. Therefore, we conducted this systematic review and meta-analysis with the aim to determine the malaria vaccine acceptance rate and the factors associated with acceptance.Methods: We searched six databases including Google Scholar, PubMed, Cochrane, African Index Medicus, The Regional Office for Africa Library, and WHO Institutional Repository for Information Sharing (IRIS) to identify studies evaluating the malaria vaccine acceptance rate. This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. Studies were included if they were original articles published in the English language in peer-reviewed journals and assessed the prevalence of willingness to accept a free malaria vaccine, and not qualitative. The risk of publication bias was checked using both Beggar’s funnel plot and Egger’s test, while the I2statistic was used to assess the heterogeneity of the included studies. Study quality was determined using the Newcastle-Ottawa scale. A meta-analysis was performed using a random effects model to evaluate the pooled prevalence of malaria vaccine acceptance. The protocol for this article was registered prospectively on the International Prospective Register for Systematic Reviews (PROSPERO), with ID number CRD42022334282).Results: Our analysis included 11 studies with a total sample size of 14, 666 participants. The aggregate malaria vaccine acceptance rate was 95.3% (95% CI:93.0%–97.2%). Among the general population, the acceptance rate was 96.3% (95% CI:92.0%–99.0%) and among mothers, it was 94.4% (95% CI:90.8%–97.2%). By country, Nigeria had the highest acceptance rate (97.6%, 95% CI:96.0%-98.8%), followed by Ghana (94.6%, 95% CI:93.8%-95.3%) and Tanzania (92.5%, 95% CI:84.4%-97.8%). Sociodemographic determinants of vaccine acceptance included place of residence, tribe, age, sex, occupation, and religion. Reasons for low acceptance included safety concerns, efficacy profile, vaccine’s requirement for multiple injections, and poor level of awareness.Conclusion: Future efforts should be focused on identifying factors that may improve the actual uptake of the RTS,S vaccine in malaria-endemic communities.

9 July 2024 in Communications Medicine
Verified
Journal Article
Open access
PDF file
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
MMMuhammad Sale Musa
Muhammad Sale Musa
BMBello Tijjani Makama
Bello Tijjani Makama
ASAbdulwahab Kabir Sulaiman
Abdulwahab Kabir Sulaiman
ABAbdulaziz T. Bako
Abdulaziz T. Bako
Background: Vaccination has been recommended as one of the most potent ways of controlling the mpox (formerly, monkeypox) outbreak, particularly among high-risk groups. Here, we evaluated the prevalence of mpox vaccine acceptance and uptake globally.Methods: We searched multiple databases for peer-reviewed studies published in English from May 2022 to 25th November 2023 that evaluated mpox vaccine acceptance and/or uptake. We fit a random-effects model meta-analysis to calculate the pooled mpox vaccine acceptance and uptake rates, with their 95% confidence intervals (CI) across population outcomes. We performed subgroup analyses among the six World Health Organization (WHO) regions (Africa [AFR], Region of the Americas [AMR], South-East Asia Region [SEAR], European Region [EUR], Eastern Mediterranean Region [EMR], and the Western Pacific Region [WPR]), as well as among select population subgroups.Results: Of the 2531 studies screened, 61 studies, with a cumulative sample size of 263,857 participants from 87 countries were eligible for inclusion. The overall vaccine acceptance and uptake rates were 59.7% and 30.9% globally. Acceptance and uptake rates among the LGBTQI+ community were 73.6% vs 39.8% globally, 60.9% vs. 37.1% in AMR, 80.9% vs. 50.0% in EUR, and 75.2% vs. 33.5% in WPR. Among PLHIV, vaccine acceptance and uptake rates were 66.4% vs. 35.7% globally, 64.0% vs. 33.9% in AMR, 65.1% vs. 27.0% in EUR, and 69.5% vs. 46.6% in WPR. Among healthcare workers, vaccination intention was 51.0% globally.Conclusions: Tailored interventions are needed to bolster confidence in the mpox vaccine, maximize vaccine uptake, and increase vaccine access to close the gaps between acceptance and uptake especially among key populations residing in regions with low rates of acceptance and uptake.

30 October 2023 in Nature Human Behaviour
Verified
Journal Article
Open access
PDF file
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
MMMuhammad Sale Musa
Muhammad Sale Musa
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
ASAbdulwahab Kabir Sulaiman
Abdulwahab Kabir Sulaiman
ABAbdulaziz T. Bako
Abdulaziz T. Bako
People living with HIV (PLHIV) are at higher risk of poor outcomes of SARS-CoV-2 infection. Here we report the pooled prevalence of COVID-19 vaccine acceptance/uptake and determinants among this vulnerable population of PLHIV based on a systematic review and meta-analysis of studies published by 25 August 2023. Among the 54 included studies (N = 167,485 participants), 53 (N = 166,455) provided data on vaccine acceptance rate, while 27 (N = 150,926) provided uptake data. The global prevalences of COVID-19 vaccine acceptance and uptake were 67.0% and 56.6%, respectively. Acceptance and uptake rates were 86.6% and 90.1% for the European Region, 74.9% and 71.6% for the Region of the Americas, 62.3% and 78.9% for the South-East Asian Region, 64.6% and 19.3% for the Eastern Mediterranean Region, 58.0% and 35.5% for the African Region, and 57.4% and 44.0% for the Western Pacific Region. The acceptance rate increased from 65.9% in 2020 to 71.0% in 2022, and the uptake rate increased from 55.9% in 2021 to 58.1% in 2022. Men, PLHIV aged ≥40 years and those who had recently received the influenza vaccine were more likely to accept and receive the COVID-19 vaccine. Factors associated with lower uptake included Black race, other races (Latinx/Hispanic/mixed race), low education level and being unemployed. Vaccine-related factors associated with higher acceptance included belief in vaccine effectiveness, vaccine trust, perceived high susceptibility to SARS-CoV-2 infection and fear of potential COVID-19 effect in PLHIV. Sustained efforts and targeted interventions are needed to reduce regional disparities in COVID-19 vaccine uptake among PLHIV.

23 February 2023 in Vaccine
Verified
Journal Article
Closed access
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
MMMuhammad Sale Musa
Muhammad Sale Musa
FTFatimah Isma'IL Tsiga-Ahmed
Fatimah Isma'IL Tsiga-Ahmed
FDFarouq Muhammad Dayyab
Farouq Muhammad Dayyab
ASAbdulwahab Kabir Sulaiman
Abdulwahab Kabir Sulaiman
SSSaeed Sulaiman
Saeed Sulaiman

SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
MoezAlIslam Ezzat FarisMoezAlIslam Ezzat Faris
MoezAlIslam Ezzat Faris
MMMuhammad Sale Musa
Muhammad Sale Musa
AUABASI-OKOT UDOYEN
ABASI-OKOT UDOYEN
Moien AB KhanMoien AB Khan
Moien AB Khan
The Islamic month of Ramadan is marked by fasting, when Muslims refrain from eating and drinking from dawn to sunset, which has an impact on their dietary habits. The study aimed to assess Nigerian Muslims’ dietary modifications during Ramadan and their related changes in body weight and health status. A web-based cross-sectional study was conducted among Nigerian adult Muslims. The survey assessed sociodemographic, dietary habits, eating behaviors, food choices, perceived weight changes, and health status. The logistic regression model was used to assess the predictors of weight change and perceived health status. There were 770 participants, 62.9% of whom were women, ranging in age from 18 to 60 years with a mean age of 27.7 ± 6.4 years. Fruits, palm dates, homemade foods, milk products, and vegetables were more frequently consumed. There were fewer energy drinks, pastries, salty snacks, and carbonated or sugared drinks consumed during Ramadan than before. Over half (54.6%, 95% CI: 51.0–58.9%) of the respondents lost weight during Ramadan, 37.0% (95% CI: 17.4–38.6%) maintained their weight and 8.4% (95% CI: 6.6–10.6%) gained weight during the month. Nearly all (97.3%, 95% CI: 95.8–98.3%) reported having good health during Ramadan, and 2.7% (95% CI: 1.7–4.1%) reported having a poorer health state during Ramadan. There was a significant weight loss and healthy dietary change associated with Ramadan fasting in Nigeria. Public health measures must be in place to impart such positive health behaviors so that such healthy habits continue throughout the year.

21 April 2024 in Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
MMMuhammad Sale Musa
Muhammad Sale Musa
FTFatimah Isma’iL Tsiga-Ahmed
Fatimah Isma’iL Tsiga-Ahmed
SASaidu Idris Ahmad
Saidu Idris Ahmad
SHSalisu Abubakar Haruna
Salisu Abubakar Haruna
ABAbdulaziz Tijjani Bako
Abdulaziz Tijjani Bako